Journal of Clinical Toxicology : Citations & Metrics Report
Articles published in Journal of Clinical Toxicology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Toxicology has got h-index 20, which means every article in Journal of Clinical Toxicology has got 20 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical Toxicology.
| Journal total citations count | 2911 |
| Journal impact factor | 5.72 |
| Journal 5 years impact factor | 8.04 |
| Journal cite score | 9.78 |
| Journal h-index | 20 |
| Journal h-index since 2019 | 16 |
Important citations (838)
mutations in ski in shprintzen-goldberg syndrome lead to attenuated tgf-? responses through ski stabilization. |
|
mutations in ski in shprintzen-goldberg syndrome lead to attenuated tgf-? responses through ski stabilization |
|
tgf?1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. |
|
epigallocatechin gallate (egcg) suppresses epithelial-mesenchymal transition (emt) and invasion in anaplastic thyroid carcinoma cells through blocking of tgf-?1/smad signaling pathways |
|
safety and activity of the tgf? receptor i kinase inhibitor galunisertib plus the anti-pd-l1 antibody durvalumab in metastatic pancreatic cancer |
|
clinical evaluation of unselected cardiac arrest survivors in a tertiary center over a 1-year period (the lazaruz study) |
|
effect of ramosetron on qtc interval: a randomised controlled trial in patients undergoing off-pump coronary artery bypass surgery |
|
clinical development of galunisertib (ly2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway |
|
first-in-human dose study of the novel transforming growth factor-? receptor i kinase inhibitor ly2157299 monohydrate in patients with advanced cancer and glioma |
|
selective inhibition of tgf?1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape. |
|
stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ecm interactions. |
|
phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor i, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma. |
|
global anti-tumor immunity after localized, bioengineered treg depletion |
|
phase 1 study of galunisertib, a tgf-beta receptor i kinase inhibitor, in japanese patients with advanced solid tumors. |
|
paraphenylenediamine hepatotoxic effects in adult female albino rats |
|
a mini review: ethical usage of animals in pharmacological research |
|
effect of zinc oxide addition on antimicrobial and antibiofilm activity of hydroxyapatite: a potential nanocomposite for biomedical applications |
|
Sorption of ni(ii), pb(ii) and cu(ii) ions from aqueous solutions by cellulose grafted with poly(hema-co-aac): kinetic, isotherm and thermodynamic study |
|
intake of heavy metals through milk and toxicity assessment |
|
Impact of birth weight and neonatal nutritional interventions with micronutrients and bovine colostrum on the development of piglet immune response during the peri-weaning period. |
|